This comprehensive text provides clear explanations of the effects of drugs on human performance and the need for workplace drug testing. It provides essential information on the regulatory and legal frameworks around the world, how to set policies and coverage of all aspects of drug analysis and the associated interpretation of results.Contents include:* epidemiology of drug use in the working population* the evidence base and guidelines for workplace drug testing* legal, regulatory aspects and policies for drugs and alcohol* urine and alternative sample collection process* analytical techniques and specimen adulteration.Case studies of successful programmes are also included to illustrate the principles discussed.Written by internationally acknowledged experts this informative book will be essential reading for anyone interested in workplace drug testing or setting up such a system including clinical and forensic toxicologists, occupational health physicians, nurses, human resources, drug counselling and treatment providers, analytical chemists and lawyers.Alain Verstraete is Professor at the Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium and Department Head of the Toxicology Laboratory of the Laboratory of Clinical Biology, Ghent University Hospital, Ghent, Belgium.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

"This study ..., conducted by the Criminal Justice Research Division of the San Diego Association of Governments (SANDAG), used the Arrestee Drug Abuse Monitoring (ADAM) program to document methamphetamine use and its consequences among arrestees ... in five cities: Los Angeles, San Diego, and San Jose in California; Phoenix, Arizona, and Portland, Oregon"--P. ix-x.

In its steady march across the United States, methamphetamine has become, to quote former Attorney General Alberto Gonzales, OC the most dangerous drug in America.OCO As a result, there has been a concerted effort at the local level to root out the methamphetamine problem by identifying the people at its sourceOCothose known or suspected to be involved with methamphetamine. Government-sponsored anti-methamphetamine legislation has enhanced these local efforts, formally and informally encouraging rural residents to identify meth offenders in their communities. Policing Methamphetamine shows what happens in everyday lifeOCoand to everyday lifeOCowhen methamphetamine becomes an object of collective concern. Drawing on interviews with users, police officers, judges, and parents and friends of addicts in one West Virginia town, William Garriott finds that this overriding effort to confront the problem changed the character of the community as well as the role of law in creating and maintaining social order. Ultimately, this work addresses the impact of methamphetamine and, more generally, the war on drugs, on everyday life in the United States.

This guide to small area estimation aims to help users compile more reliable granular or disaggregated data in cost-effective ways. It explains small area estimation techniques with examples of how the easily accessible R analytical platform can be used to implement them, particularly to estimate indicators on poverty, employment, and health outcomes. The guide is intended for staff of national statistics offices and for other development practitioners. It aims to help them to develop and implement targeted socioeconomic policies to ensure that the vulnerable segments of societies are not left behind, and to monitor progress toward the Sustainable Development Goals.